Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease

被引:60
作者
Chen, Jing [1 ,2 ,3 ]
Hamm, L. Lee [1 ,2 ]
Mohler, Emile R. [4 ]
Hudaihed, Alhakam [1 ]
Arora, Robin [1 ]
Chen, Chung-Shiuan [3 ]
Liu, Yanxi [3 ]
Browne, Grace [3 ]
Mills, Katherine T. [3 ]
Kleinpeter, Myra A. [1 ]
Simon, Eric E. [1 ]
Rifai, Nader [5 ]
Klag, Michael J. [6 ]
He, Jiang [1 ,2 ,3 ]
机构
[1] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70118 USA
[2] Tulane Univ, Sch Med, Tulane Hypertens & Renal Ctr Excellence, New Orleans, LA 70118 USA
[3] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA
[4] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[5] Harvard Univ, Sch Med, Childrens Hosp, Dept Pathol, Boston, MA 02115 USA
[6] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
来源
PLOS ONE | 2015年 / 10卷 / 07期
基金
美国国家卫生研究院;
关键词
FLOW-MEDIATED DILATION; INCIDENT CARDIOVASCULAR EVENTS; ASYMMETRIC DIMETHYLARGININE; BRACHIAL-ARTERY; RENAL-INSUFFICIENCY; DEATH; INFLAMMATION; DIALYSIS; VASODILATATION; PROGRESSION;
D O I
10.1371/journal.pone.0132047
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The interrelationship of multiple endothelial biomarkers and chronic kidney disease (CKD) has not been well studied. We measured asymmetric dimethylarginine (ADMA), L-arginine, soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin), von Willebrand factor (vWF), flow-mediated dilation (FMD), and nitroglycerin-induced dilation (NID) in 201 patients with CKD and 201 community-based controls without CKD. Multivariable analyses were used to examine the interrelationship of endothelial biomarkers with CKD. The multivariable-adjusted medians (interquartile ranges) were 0.54 (0.40, 0.75) in patients with CKD vs. 0.25 (0.22, 0.27) mu mol/L in controls without CKD (p<0.0001 for group difference) for ADMA; 67.0 (49.6, 86.7) vs. 31.0 (27.7, 34.2) mu mol/L (p<0.0001) for L-arginine; 230.0 (171.6, 278.6) vs. 223.9 (178.0, 270.6) ng/mL (p=0.55) for sICAM-1; 981.7 (782.6, 1216.8) vs. 633.2 (507.8, 764.3) ng/mL (p<0.0001) for sVCAM-1; 47.9 (35.0, 62.5) vs. 37.0 (28.9, 48.0) ng/mL (p=0.01) for sE-selectin; 1320 (1044, 1664) vs. 1083 (756, 1359) mU/mL (p=0.008) for vWF; 5.74 (3.29, 8.72) vs. 8.80 (6.50, 11.39)% (p=0.01) for FMD; and 15.2 (13.5, 16.9) vs. 19.1 (17.2, 21.0)% (p=0.0002) for NID, respectively. In addition, the severity of CKD was positively associated with ADMA, L-arginine, sVCAM-1, sE-selectin, and vWF and inversely associated with FMD and NID. Furthermore, FMD and NID were significantly and inversely correlated with ADMA, L-arginine, sVCAM-1, sE-selectin, and vWF. In conclusion, these data indicate that multiple dysfunctions of the endothelium were present among patients with CKD. Interventional studies are warranted to test the effects of treatment of endothelial dysfunction on CKD.
引用
收藏
页数:10
相关论文
共 50 条
[41]   Endothelial Dysfunction and Atherosclerosis in Patients With Autosomal Dominant Polycystic Kidney Disease [J].
Ekinci, Iskender ;
Buyukkaba, Mitat ;
Cinar, Ahmet ;
Tunc, Muhammed ;
Cebeci, Egemen ;
Gursu, Meltem ;
Kazancioglu, Rumeyza .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
[42]   Emerging biomarkers of chronic kidney disease in children [J].
Greenberg, Jason H. ;
Kakajiwala, Aadil ;
Parikh, Chirag R. ;
Furth, Susan .
PEDIATRIC NEPHROLOGY, 2018, 33 (06) :925-933
[43]   The Use of Targeted Biomarkers for Chronic Kidney Disease [J].
Devarajan, Prasad .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2010, 17 (06) :469-479
[44]   New and Emerging Biomarkers in Chronic Kidney Disease [J].
Dopierala, Mikolaj ;
Nitz, Nadja ;
Krol, Oliwia ;
Wasicka-Przewozna, Karolina ;
Schwermer, Krzysztof ;
Pawlaczyk, Krzysztof .
BIOMEDICINES, 2025, 13 (06)
[45]   Targeted biomarkers of progression in chronic kidney disease [J].
Owens, Evan Paul ;
Healy, Helen Grania ;
Vesey, David Alan ;
Hoy, Wendy Elizabeth ;
Gobe, Glenda Carolyn .
CLINICA CHIMICA ACTA, 2022, 536 :18-28
[46]   Epoetin beta pegol prevents endothelial dysfunction as evaluated by flow-mediated dilation in chronic kidney disease rats [J].
Serizawa, Kenichi ;
Yogo, Kenji ;
Tashiro, Yoshihito ;
Aizawa, Ken ;
Kawasaki, Ryohei ;
Hirata, Michinori ;
Endo, Koichi .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 767 :10-16
[47]   Relation between serum cathepsin D levels and endothelial dysfunction in patients with chronic kidney disease [J].
Ozkayar, Nihal ;
Piskinpasa, Serhan ;
Akyel, Fatma ;
Turgut, Didem ;
Bulut, Mesudiye ;
Turhan, Turan ;
Dede, Fatih .
NEFROLOGIA, 2015, 35 (01) :72-79
[48]   Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients [J].
Chitalia, Nihil ;
Recio-Mayoral, Alejandro ;
Kaski, Juan Carlos ;
Banerjee, Debasish .
ATHEROSCLEROSIS, 2012, 220 (01) :265-268
[49]   Red Cell Distribution Width Is Independently Related to Endothelial Dysfunction in Patients With Chronic Kidney Disease [J].
Solak, Yalcin ;
Yilmaz, Mahmut I. ;
Saglam, Mutlu ;
Caglar, Kayser ;
Verim, Samet ;
Unal, Hilmi U. ;
Gok, Mahmut ;
Demirkaya, Erkan ;
Gaipov, Abduzhappar ;
Kayrak, Mehmet ;
Cetinkaya, Hakki ;
Eyileten, Tayfun ;
Turk, Suleyman ;
Vural, Abdulgaffar .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 347 (02) :118-124
[50]   Dyslipidemia, carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease [J].
Khandelwal, Priyanka ;
Murugan, Vijaya ;
Hari, Smriti ;
Lakshmy, Ramakrishnan ;
Sinha, Aditi ;
Hari, Pankaj ;
Bagga, Arvind .
PEDIATRIC NEPHROLOGY, 2016, 31 (08) :1313-1320